Fresenius Medical Care | FME - Ativo Circulante





Ativo Circulante Alterar Data
Akzo Nobel EUR 7.53B 1.47B 2026-03
Alcon AG USD 6.62B 171M 2026-03
AstraZeneca USD 29.61B 890M 2026-03
Bayer EUR 35.3B 2.39B 2026-03
Beiersdorf EUR 6.66B 8M 2025-12
DaVita Healthcare Partners USD 4.06B 4.68M 2026-03
Demant DKK 10.08B 128M 2025-12
E.ON EUR 28.03B 5.75B 2026-03
Essilor EUR 12.01B 981M 2025-12
Fresenius EUR 11.03B 1.03B 2025-12
Fresenius Medical Care EUR 8.11B 209.55M 2026-03
Genmab DKK 2.88B 1.59B 2025-12
Getinge SEK 18.16B 1.83B 2024-12
Givaudan CHF 4.07B 258M 2025-12
GlaxoSmithKline GBP 17.76B 251M 2026-03
GN Store Nord DKK 4.85B 3.79B 2026-03
GRIFOLS EUR 5.25B 180M 2026-03
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Lonza CHF 8B 3.41B 2025-12
Merck EUR 14.16B 932M 2026-03
Novartis USD 26.61B 3.85B 2026-03
Philips EUR 9.78B 148M 2026-03
Roche Holding CHF 38.73B 3.03B 2025-12
RWE EUR 45.61B 11.27B 2026-03
Sanofi EUR 30.16B 789M 2026-03
SAP EUR 22.26B 2B 2026-03
Smith & Nephew USD 4.63B 169M 2025-12